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Abstract We have measured the X-ray fluorescence from
gadolinium as a function of concentration and position in
tumors of different sizes and shapes in a head phantom.
The gadolinium fluorescence was excited with a 36 GBq
Am-241 source. The fluorescence signal was detected with
a CdTe detector and a multi-channel analyzer. The fluorescence peak was clearly separated from the scattered
X-rays. Concentrations of 5.62–78.63 mg/ml of Gd ion
were used in 1, 2, and 3 cm diameter spherical tumors and
a 2 9 4 cm oblate spheroid tumor. The data show trends
approaching saturation for the highest concentrations,
probably due to reabsorption in the tumor. A comparison of
X-ray photographic imaging and densitometer measurements to determine concentration is also presented.
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Introduction
In recent years gadolinium (Gd) has received attention in
research for its application to neutron capture therapy. Gd
neutron capture reactions produce Auger electrons, A,
internal conversion electrons, IC, prompt gamma rays, c,
and X-rays.
157

Gd þ nth !158 Gd þ c þ X-rays þ ICe þ A e ;
Q  7:94 MeV

.
The Auger electrons and higher energy electrons induce
double strand DNA cleavage. The long range gamma rays
that are released in the 157Gd(n, c) reaction can deliver a
dose to the healthy tissue, which reduces the localization
effect of neutron capture therapy but also increases the
probability of striking all the tumor cells [1–4]. Only a
small fraction of the dose penetrates the surrounding normal tissue [5–8]. If neutron capture by Gd is going be used,
it is important to assess the dose delivered to the patient,
which means it is important to know the amount of the Gd
inside the brain tumor, either before or during exposure to
the neutrons [9]. The current magnetic resonance imaging
technique (MRI) does not provide adequate information for
two reasons. First, the technique is generally qualitative.
Second, the imaging takes a long time, during which part of
the Gd will have been biologically eliminated. Information
on concentration, build-up, or elimination of the Gd from
an organ is significant in Gd neutron therapy [10, 11].
There are many possible ways to determine the concentration of the Gd in the tumor. The first method that we
investigated was to measure the attenuation of the X-rays
by the Gd. The attenuation could be measured with dual
image subtraction, subtracting the image before the Gd is
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injected, from the image after the Gd is injected. Alternatively, dual energy subtraction could be used where the
image from a detector sensitive to X-ray photons with
energies less than the k-edge absorption is subtracted from
an image created by a detector sensitive to X-ray photons
with energies greater than the k-edge of Gd. A simplified
method of X-ray absorption is to use an X-ray tube with a
potential greater than 70 kV. This would emit X-rays and
the majority of the photons would have energies greater
than the k-edge of Gd. So, the resulting image is dominated
by the Gd absorption. It is this simplified technique using a
single X-ray image that we investigated here.
The other technique we used to determine the Gd concentration was to measure the X-ray fluorescence. Here, a
monochromatic source of X-rays with an energy above the
k-edge of Gd is incident upon the tumor. The scattered
X-rays with the characteristic energy of the fluorescence
are then counted. We investigate these two different
methods of noninvasively measuring Gd concentration in a
brain tumor using a head phantom.

Materials and methods
Phantom
Variables of the measurement were: tumor size, depth of
the tumor, concentration of the Gd solution and tumor
geometry. These parameters were measured with a transparent head phantom (Churchin Association, Smithtown,
NY, USA). This phantom was supplied with 1, 2, and 3 cm
diameter spherical tumor vessels and a 2 9 4 cm oblate
spheroid tumor vessel. These vessels, simulating the tumor,
could be filled with water and a known concentration of Gd
and placed in specific locations in the head phantom.
The head phantom, containing Gd agent in a tumor
vessel, was put in front of an Am-241 source. Lateral and
vertex positions of the head phantom were taken, with the
X-ray detector positioned as shown in Fig. 1. The characteristics X-ray measured was 42.98 keV.
In Fig. 1, we show a drawing of the set up with the
source and detector in the lateral position. The position of
the tumor in the skull is determined with a laser sight (not
shown) allowing us to determine the position of the tumor
to better than ±1.0 mm. The distance from the inside of the
skull to the center of the tumor is the tumor depth. The
source is positioned 6 cm from the exterior of the skull.
The dashed arrows show the incident and emitted radiation.
X-ray imaging
To obtain the size and the shape of the tumor by the radiographic method, a general X-ray machine with radiograph
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Fig. 1 The head phantom containing the tumor vessel is shown. The
source and detector are in the lateral position. The source and detector
are also shown as a lighter image in the vertex position

film was used. The left lateral of the head phantom was put
in contact with the table and the median sagittal plane was
parallel to the film. The X-ray beam was perpendicular to the
film and sagittal plane. The central ray was centered to the
right external auditory meatus. Radiographic exposure factors of the experiments were fixed at 73 kVp, 20 mA, with a
source film distance of 105 cm. The cassette size was a
24 cm 9 30 cm. The film was developed with standard
techniques and the optical density of the film was measured
with a Model 07-443 Densitometer (Nuclear Associates,
Division of Victoreen Inc, Phoenix, USA). The differences
of optical density in the X-rays films were obtained when the
densities from the center of the tumor vessels were subtracted from the densities of the darkest point on the X-ray
films (outside the image of the head phantom).
X-ray fluorescence
To measure the X-ray fluorescence, Gd atoms in the tumor
vessel were excited by a 36 GBq (0.97 Ci) of Am-241
source (T1/2 = 432.7 years). It produced 59.5 keV gamma
rays with a relative intensity of 0.357 per disintegration.
The emitted characteristic fluorescence radiation was
measured by a cadmium telluride (CdTe) detector (Amptek
Inc, USA). The XR-100T-CdTe detector had 1.0 mm thick
of CdTe and a 100 lm thick beryllium window. The
position of the detector is beside the Am-241 source, which
is mounted on the column of tungsten, at a 138° angle with
respect to the axis of the gamma ray beam. The distance
from the surface of the head phantom to the Am-241 source
was adjusted to be 6.0 cm and the exposure time was
chosen to be real time and set for 30 min. The different size
and shape of the tumor vessels were selected for exposure.
These sizes were spheres with diameters of 1.0, 2.0, and
3.0 cm, and an oblate spheroid with 2.0 9 4.0 cm diameters. The depths of the tumor were measured from the
surface of the head phantom to the center of the tumor
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excited because their excitation energies are above the
59.5 keV from the Am-241.

Results
X-ray fluorescence
The scattering angle for the setup was determined to be
approximately 138°. At 138° the Compton scattering of the
incident radiation (59.5 keV) made a broad peak near
49 keV. The Ka characteristic X-ray peak of the Gd atoms
(42.98 keV) was clear and easily separated from the scattered photon peak (49 keV) as shown in Fig. 2.
In Fig. 3, we show the measured intensities from the
1 cm diameter tumor in the phantom head without water in
the head and measured with the source and detector in the
lateral position. The depth of the tumor was 0.5–5.5 cm in

Fig. 2 Spectrum of the Ka characteristic X-ray of the Gd obtained
from a 3 cm diameter tumor vessel, which contained 50.55 mg/ml of
Gd at a depth of 1.0 cm and measured in the lateral position

90000
80000

Total counts for 30 min

vessel. The depths ranged from 0.5 to 5.5 cm between the
center of the tumor and interior wall of the skull.
The X-ray photons were digitized on the Genie 2000 PC
multichannel analyzer (MCA) (Canberra Company, Meriden, CT, USA). The intensity of the fluorescence peak is
obtained by fitting the background to a cubic equation
subtracting the background and then integrating the fluorescence. Concentrations from 5.62 to 78.63 mg/ml of Gd
ion in the tumor vessel were used in the phantoms. The Gd
is a constituent of the commercial contrast agent, Magnevist (Schering AG, Germany).
The total counts of the fluorescence peak was measured
as a function of the Gd concentration and as a function of
the tumor depth for tumor vessels of the following sizes:
1.0, 2.0, 3.0, and 2.0 9 4.0 cm. For each tumor, two
measurements were made: the first for the tumor with the
skull filled with water to mimic biologic tissue, the second
for one without water. When using the 1.0 cm tumor the
total amount of Gd in the tumor was small, and it was
difficult to measure the fluorescence X-rays from Gd when
the head phantom was filled with water. Therefore, all the
experiments for the 1.0 cm tumor were conducted only in
the head phantom without water.
Although it is not physiological to not put water into the
head phantom, a comparison of the two measurements,
with and without water, should indicate only the attenuation of the water. Thus, one can check that the measured
counts are reasonable and the measurement geometry is as
expected. Since the attenuation of the water in the head
phantom should only change with the location of the tumor
and not the concentration of Gd in the tumor, we took the
measured counts for each position with the head full of
water and divided by the measured counts for each position
with the head empty. This number is always less than 1.0
and represents the attenuation of the water in the head
phantom. The measured attenuation is compared with the
expected attenuation of water.
The Gd X-ray fluorescence (XRF) peak is at
42.98 keV. It is important to consider if this peak overlaps any other X-ray peak and might distort the measurements. Materials subject to direct radiation from the
source are carbon, nitrogen, oxygen and hydrogen from
brain tissue and calcium and phosphorous from the skeletal bones. All these elements have XRF peaks that are
far below the Gd XRF peak. The highest energy peak is
that of calcium at about 4 keV. Materials that might be
subject to secondary radiation are Cd and Te from the
CdTe detector itself, W or Pb if any of these elements are
used for collimation. Cd and K lines are at about 23 keV,
while those of Te are at about 27 keV; both are far from
the Gd peak. Moreover, because the secondary radiation
intensity is much less than the primary beam, the excitation will be small. Lead or tungsten atoms will not be
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Fig. 3 Integrated counts of X-ray fluorescence of Gd as a function of
the depth in the head phantom for a 1 cm diameter spherical tumor
measured in the lateral position. The phantom skull was not filled
with water. The filled diamonds are measured with a concentration
15.73 mg/ml of Gd, the filled triangles are with 31.45 mg/ml, the
open diamonds are with 47.18 mg/ml, the open triangles are with
62.9 mg/ml, the open circles are with 78.63 mg/ml. The lines are
drawn to guide the eye
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Fig. 4 Integrated counts of X-ray fluorescence of Gd as a function of
the Gd concentration for a 2 cm diameter spherical tumor measured in
the lateral position. The tumor is 2.0 cm inside the skull. The
triangles were measured when the phantom skull was not filled with
water. The circles were measured when the phantom skull was filled
with water. The lines are drawn to guide the eye

0.5 cm steps. We plot the total counts as a function of the
tumor depth, for each Gd concentration. This figure shows
that the total counts decreased as the tumor depth increased
inside the head phantom, as one would expect.
Figure 4 shows the comparisons of the total counts of
the Gd X-ray fluorescence as a function of the Gd concentration for the head phantom with and without water.
The measurements were taken at the depth of 2.0 cm for a
spherical tumor vessel with a diameter 2.0 cm. The figures
show that the total counts increase as the concentration
increased and they were higher for the phantom head
without water. Similar data were collected at all depths.
The relationship between the measured attenuation of
the water in the skull using the different Gd concentrations
(mg/ml) and the different tumour depths are shown in
Fig. 5. The line is the predicted attenuation for the known
scattering and absorption of water. The incident radiation
of 59.5 keV from the source and the emitted characteristic
X-ray of 42.98 keV undergo attenuation by the water
inside the head phantom in the lateral position. The
attenuation of the incoming 59.5 keV gamma ray is given
by exp[-l (59.5 keV) x], while the attenuation due to the
emitted characteristic X-ray of 42.98 keV is exp[-l
(42.98 keV) x0 ], where x and x0 are the distance of the
incident radiation and emitted characteristic X-ray,respectively, that travel through the water. The correlation
between the attenuation of the experimental measured and
the calculated attenuation was observed with an R2 = 0.72.
X-ray imaging
Radiographic images are shown in Fig. 6. In this case the
tumor of 3 cm diameter containing the Gd agent, was
placed at a 1.5 cm depth inside a head phantom containing
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Fig. 5 Fractional number of counts from tumors measured with water
in the head phantom to no water in the head phatom measured at
different tumor depths and tumor sizes and concentrations of Gd. The
large dots are 3 cm tumor sizes, with black being 79 mg/ml Gd, dark
gray is 62 mg/ml Gd, medium gray is 51 mg/ml Gd, light gray is
28 mg/ml Gd and white is 5.6 mg/ml Gd. The small dots are 2 cm
tumor sizes, with black being 79 mg/ml Gd, dark gray is 67 mg/ml
Gd, medium gray is 45 mg/ml Gd, and white is 22 mg/ml Gd. The
ovals are the 2 9 4 cm tumor sizes with black being 79 mg/ml Gd,
dark gray is 58 mg/ml Gd, medium gray is 41 mg/ml Gd, light gray is
25 mg/ml Gd and white is 8.3 mg/ml Gd. The line is an exponential
fit of water attenuation. The R2 of the fit = 0.72

water. The radiographic film shows the tumor image with
Gd concentrations of 0.56 mg/ml in (A) and 78.63 mg/ml
in (B). The presence of the Gd compound in the tumor
vessel inside the head phantom was clearly visualized on
the radiographic film. The outline of the tumor vessel was
apparent. As the concentration of Gd was increased, the
clarity of the image of the tumor improved. The differences
of optical density in the X-rays films as shown in Fig. 7
were obtained when the densities from the center of the
tumor vessels were subtracted from the densities of the
darkest point on the X-ray films. This figure shows that
the ‘‘noise’’ in the film density was excessive with the
lower concentrations of the Gd.

Discussion
Magnevist is a well-known agent for magnetic resonance
image (MRI) tumor imaging and contains Gd; this element
has the highest cross-section for thermal neutrons and
shows promise for Gd neutron capture therapy. The maximum Gd concentration was limited by its concentration in
the Magnevist, where one milliliter of Magnevist solution
contains 469 mg of gadopentetic acid and dimeglumine
salt, this corresponds to 78.63 mg of Gd. Throughout this
article, we report on the concentration of Gd ion that is
present in the tumor.
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Fig. 6 Radiograph of the 3 cm tumor vessel 1.5 cm inside the
head phantom taken at 73 KVp. 20 mA, and at 105 cm SFD. In a the
Gd concentration is 0.56 mg/ml, in b the Gd concentration is
78.63 mg/ml
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Fig. 7 Difference of optical density (center of the tumor compared to
area immediately adjacent to the tumor) versus concentration of Gd in
a 3.0 cm diameter tumor vessel, at 1.5 cm depth inside the head
phantom, in the lateral position. The smooth line between the data
points is drawn to guide the eye

The sizes and the shapes of the tumors in the brain
phantom were confirmed by radiographic film of the tumor
vessels. These contained different concentrations of Gd

inside the head phantom filled with water as shown in
Fig. 6. The radiographic film was taken of a 3.0 cm diameter tumor vessel in the lateral position at 1.5 cm depth with
different Gd concentrations such as 0.56 and 78.63 mg/ml.
As the Gd in the tumor vessel has a high atomic number and
high density, the incident gamma radiation interaction
would be increased, leading to increased photon attenuation,
which in turn made the tumor vessel appear very bright on
the film. Consequently, the greater the concentration of Gd,
the clearer the tumor image appeared. However, as shown in
Fig. 7, it is not practical to determine the concentration of
Gd from the density on the film. Even though a difference in
optical density is plotted, partially compensating for film
age, strength of the film processing chemicals and other
variables, the optical density differences have a significant
amount of noise for the lower concentrations.
The minimum value of the Gd concentration for each of
the four tumors was limited by the minimum detectable
level of fluorescence by the detector. The results show that
the total fluorescence counts increased as the concentration
of the Gd in the tumor vessel increased, as expected. The
relation between the counts and the concentration for each
measurement does not follow a straight line (see Fig. 4),
possibly due to self absorption of the X-ray emissions
inside the tumor vessel. As the Gd concentration increases,
a higher fraction of the emitted characteristic X-rays is
absorbed within the tumor. This leads to a fluorescence
intensity that shows a tendency towards saturation rather
than a linear increase.
The other factor impacting on the experimental outcome
was the location of the tumor vessel inside the head
phantom (i.e. the depth of the tumor as measured from the
surface of the skull to the center of the tumor vessel).
Measurements showed that at a depth of 2.0 cm for the
tumor vessel with a diameter of 1.0 cm and also, at a depth
of 2.5 cm for tumors size of 2.0, 3.0, and 2.0 9 4.0 cm
with a minimum concentration of Gd (15.73 mg/ml) the
fluorescence signal was not separable from the background.
Furthermore, it was clear that the deeper the tumor was
inside the head phantom, the lower the counts. That was, in
part, due to the increased distance from the CdTe detector
and from the Am-241 source and owing to the attenuated
and absorption of incident as well as emitted characteristic
X-ray in the water inside both the tumor and in the head
phantom. The tumor was not a point source and, therefore,
the counts do not follow exactly the inverse square law.
The effect of water absorption (water is closely equivalent to biological tissue, as effective atomic number of
water and tissue are both 7.4) was found when the experiment was repeated without water inside the head phantom.
In these results, the counts were lower for the head phantom containing water than those of the empty head phantom under the same condition (i.e. tumor size, tumor depth,
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and Gd concentration). The results of the characteristic
X-ray, between the head phantom with and without water,
are shown in the tumor vessel 2.0 cm diameter at a depth of
2.0 cm and containing 78.63 mg/ml of Gd concentration at
the vertex position, where the total count from the head
phantom containing water was 149,502 compared with
218,100 counts from the head phantom without water. The
total count was reduced by factor 1.5. On the other hand, at
a depth of 4.5 cm in the tumor vessel of 3.0 cm diameter,
the total count obtained from the head phantom containing
water was 63,786 compared with 270,684 counts (reduced
by a factor of 4.2) from the empty head phantom. Counts
were reduced threefold when an irregular tumor vessel of
2.0 9 4.0 cm, at a depth of 4.0 cm, was used, where counts
from the head phantom containing water were 72,068
compared with 217,494 from head phantom without water.
Generally, in the same conditions (i.e. tumor size, tumor
depth, and Gd concentration) the total counts without water
were higher. The only effect that is responsible for the
difference in total counts is the presence of water inside
the head phantom. This water caused the attenuation of the
incident 59.5 keV and the X-ray emitted from the tumor
vessel.
Total counts from the three tumor sizes inside the head
phantom in the lateral and vertex positions, showed consistency and a tendency for saturation at higher concentration. Total counts obtained from the tumor vessels of
2.0, 3.0 and 2.0 9 4.0 cm at depths of 1.5 and 2.0 cm,
respectively, in the head phantom containing water, shows
that increasing the tumor vessel size, increases the total
counts for the tumor vessel depths. It should be noted that
no results were obtained for the 1.0 cm tumor, with water
in the head phantom. Also, it can be observed that for the
same total amount of Gd, different counts are obtained by
using different shapes. The highest counts were obtained
from 3.0 cm tumor. The 1.0 cm tumor gave the lowest
counts because it contained the least amount of total Gd.
The collection time used for the fluorescence signal
detection in this work was 30 min. This is too long for
measuring instantaneous concentration. On the other hand,
the source activity used was 0.97 Ci (3.6 9 1010 Bq). In
order to reduce counting time, source activity could be
increased. Source activity of about 100 Ci (3.7 9 1012 Bq)
is practical and can reduce collection time to about 0.3 min
(18 s). Reduction of time can also be achieved by using a
higher efficiency detector. Our detector of CdTe had about
1 cm2 of cross-sectional area while the cylindrical scintillation detector, 5.0 inch in diameter 9 4.0 inch height,
would have about 125 times higher count rates.
The amount of Gd that reaches the tumor is approximately 300 lg/g [12]. This is about one order of magnitude
less than our detection limit. By increasing the source
activity, two orders of magnitude or increasing the
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detection efficiency two orders of magnitude, or both (four
orders of magnitude) can increase the overall efficiency
102–104 times. In this case, the detection limit can be much
less than the actual Gd concentration in the brain. Additionally, one could consider a detector that accepts a wider
angular dispersion of the fluorescence. The fluorescence is
sufficiently well resolved from the Compton scattering, that
using less collimation on the detector could increase the
detected intensity without sacrificing discrimination.
The specific exposure rate constant for Am-241 is
0.0129 R/(h-Ci) at 1 m [13]. A 100 Ci Am-241 at 50 cm
and 18 s exposure can be shown to give 0.026 R or
approximately 26 mrad, or 0.26 mGy (0.26 mSv). While
this value is larger than we prefer, it is less than the doses
received in most general diagnostic examinations and
much lower than the dose in fluoroscopy examinations.
The energy of 59.5 keV is quite suitable for this application. It is slightly above the 42.98 keV of Gd characteristics X-rays which make the probability of interaction
high. At energy less then 50 keV, the interaction is not
possible while at higher energy, the probability of interaction will decrease. One of the main advantages of
Am-241 is its long half-life. In such a case, the source can
be used for a very long time without affecting the sensitivity of the system.
X-rays from an X-ray machine could be used as a
radiation source but the continuous spectrum of radiation
will make analysis more difficult. For example, with a
continuous incident X-ray spectrum, the scattered radiation
peak coming from different components will be very wide.
The Gd characteristic peak X-rays might not be resolvable.
Moreover, the duration of exposure in most diagnostic
X-ray generators is small; a fraction of a second.
As was mentioned earlier, MRI can also be considered
to measure the concentration of Gd in brain tumors. To
make this measurement, one must first measure the post
contrast change in the T1 rate and then employ the T1
relaxivity R to determine the concentration. The value of R
can be readily measured in aqueous solution, but in the
brain the value is expected to be quite different. In a very
recent publication, the T1 relaxivity R of Gd-DTPA was
measured to be 5.34 mM-1 s-1 in a 2.4 T field in a rat
brain [14]. This value is considerably higher than previously estimated. Thus, the MRI remains qualitative until
the relaxivity R is well-established; however, MRI is sensitive to lower concentrations of Gd than we could measure
with X-ray fluorescence.

Conclusions
The analysis of the X-ray fluorescence of Gd in brain
tumors provides valuable information containing the
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concentration of the Gd in the tumor. This can be used to
calculate the effective dose to deliver to the tissue for
maximal tumor destruction. The analysis consisted of
variables that included the position of the head phantom;
size of the tumor vessel, depth of the tumor vessel inside
the head phantom and the amount of Gd in the tumor
vessel. Using X-ray fluorescence proved to be better than
trying to measure the optical density of X-ray images,
where the measurements were not consistent for low Gd
concentrations.
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